Evelyne Racadot Selected Research

Thrombocytopenia (Thrombopenia)

6/2010	Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France.
9/2006	Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evelyne Racadot Research Topics

Disease

5	Ankylosing Spondylitis 04/2011 - 07/2006
4	Thrombosis (Thrombus) 09/2012 - 09/2006
2	Thrombocytopenia (Thrombopenia) 06/2010 - 09/2006
2	Stable Angina 10/2009 - 11/2007
1	Rheumatoid Arthritis 10/2012
1	Arthritis (Polyarthritis) 04/2011
1	Thrombophilia 04/2011
1	Osteoarthritis 02/2009
1	Spondylarthropathies 02/2009
1	Hemorrhage 09/2006
1	Inflammation (Inflammations) 07/2006
1	Thrombophlebitis 01/2003
1	Virus Diseases (Viral Diseases) 10/2002
1	Disease Progression 10/2002
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2002
1	Hemorrhagic Cystitis 10/2002

Drug/Important Bio-Agent (IBA)

2	Thrombin FDA Link 10/2012 - 04/2011
2	Immunoglobulin A (IgA)IBA 04/2011 - 07/2006
2	Heparin (Liquaemin)FDA LinkGeneric 06/2010 - 09/2006
2	MetalsIBA 10/2009 - 11/2007
2	P-SelectinIBA 10/2009 - 11/2007
2	Thromboplastin (Tissue Factor)IBA 10/2009 - 07/2006
2	Glycoproteins (Glycoprotein)IBA 10/2009 - 11/2007
2	Interleukin-17 (Interleukin 17)IBA 02/2009 - 05/2007
1	AntibodiesIBA 09/2012
1	fibrin fragment D (D-dimer)IBA 04/2011
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2011
1	Pharmaceutical PreparationsIBA 10/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2009
1	Prothrombin (Factor II)IBA 10/2009
1	Factor VIIa (Activated Factor VII)IBA 10/2009
1	Fibrinogen (Factor I)FDA Link 10/2009
1	Plasminogen InactivatorsIBA 10/2009
1	Interleukin-12 (IL 12)IBA 02/2009
1	Cathepsin KIBA 10/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2008
1	Bone Morphogenetic Protein 7IBA 05/2007
1	lepirudin (Refludan)FDA Link 09/2006
1	C-Reactive ProteinIBA 07/2006
1	Antiphospholipid AntibodiesIBA 01/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2002
1	Factor XIII (Coagulation Factor XIII)IBA 10/2002
1	Busulfan (Busulfex)FDA Link 10/2002

Therapy/Procedure

2	Stents 10/2009 - 11/2007
1	Percutaneous Coronary Intervention 10/2009
1	Therapeutics 10/2008
1	Stem Cell Transplantation 10/2002